HK Stock Market Move | BeiGene (06160) opened over 3% higher after the results. Adjusted net profit in the third quarter increased by 489% year-on-year. Bai Yuze continues to expand its global market.

BEIGENE (06160) opened more than 3% higher after the performance announcement, and as of the time of writing, it was up 3.02% at 194.3 Hong Kong dollars with a trading volume of 14.4857 million Hong Kong dollars. On the news front, on November 6th, BEIGENE announced its third-quarter performance for 2025, with revenue reaching 1.412 billion US dollars, a 41% year-on-year increase. Adjusted net profit was approximately 304 million US dollars, a 489% year-on-year increase. GAAP net profit was 125 million US dollars, turning a loss into a profit. For the period of January to September, total revenue was around 3.845 billion US dollars, a 43% year-on-year increase; adjusted net profit was about 693 million US dollars, turning a loss into a profit; GAAP net profit was around 220 million US dollars, turning a loss into a profit. The announcement stated that the increase in total revenue was mainly due to the growth in sales of BeiJuZe in the United States and Europe. In the third quarter of 2025, product revenue was 1.4 billion US dollars, compared to 993 million US dollars in the same period last year. The growth in product revenue was mainly due to the increase in sales of BeiJuZe. The United States remained the company's largest market, with product revenue reaching 743 million US dollars, compared to 504 million US dollars in the same period last year. Sales of products licensed from Amgen and BaiZeAn (toripalimab monoclonal antibody) also contributed to the growth in product revenue. In addition, BEIGENE's total revenue guidance for the full year of 2025 is expected to be between 5.1 billion US dollars and 5.3 billion US dollars, including expectations of strong revenue growth, benefiting from BeiJuZe's leading position in the United States and continued expansion in Europe and other important markets globally. Compared to 2024, the gross profit margin is expected to be in the range of 80% to 90% due to improvements in the product portfolio and increased production efficiency.